borderline significantp = 0.049
In this pre-COVID-19 analysis, there were 177 events in the treatment group and 224 events in the control group, which yielded borderline significant results in favor of CardioMEMS (HR 0.81; 95% CI 0.66–1.00; p = 0.049).